In 1975, Stanford Medicine researchers discovered link between exercise and increased ‘good’ (HDL) cholesterol levels. The Coronary Primary Prevention Trial, begun in 1971 at Stanford and eleven other Centers in the US and Canada, was the first to establish the effectiveness of cholesterol lowering in preventing heart disease.

Stanford’s Lipid Research Clinic continues to provide advanced analysis of cardiovascular disease risk for patients at Stanford and to support SPRC research.